Gastrointestinal abnormalities and involvement in systemic mastocytosis (Q33979035)

30 July 2017

1 reference

title

Gastrointestinal abnormalities and involvement in systemic mastocytosis (English)

1 reference

30 July 2017

R T Jensen

1

1 reference

30 July 2017

publication date

1 June 2000

1 reference

Hematology / Oncology Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

579-623

1 reference

The effect of cimetidine and propantheline on the symptoms of a patient with systemic mastocytosis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Bleeding after liver biopsy in a patient with systemic mastocytosis and malabsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Disodium cromoglycate in the treatment of systemic mastocytosis involving only bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Gastrointestinal involvement in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis and other mast cell neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Mast cell cholangiopathy: another cause of sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Cimetidine in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Urticaria Pigmentosa as a Systemic Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Intractable ascites in systemic mastocytosis treated by portal diversion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Gastroscopic findings in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Mastocytosis and intestinal malabsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis. Extracutaneous manifestations.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Mastocytosis: one year's experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Response of severe systemic mastocytosis to interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Gastrointestinal dysfunction in systemic mastocytosis. A prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Gastrointestinal lesions in mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Idiopathic gastric acid hypersecretion. Comparison with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Ranitidine therapy in patients with idiopathic gastric acid hypersecretion. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Experimental hyperplasia of the stomach mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Interferon treatment of patients with chronic urticaria and mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

THE MASTOCYTOSIS SYNDROME: CLINICAL AND BIOLOGICAL STUDIES

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Histaminuria in urticaria pigmentosa. A clinical study and review of recent literature with definition of the mastocytosis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Getting the story right

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Beiträge zur Kenntniss der Anilinfärbungen und ihrer Verwendung in der mikroskopischen Technik

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Effects of metiamide on gastric acid hypersecretion, steatorrhea, and bone-marrow function in a patient with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Intestinal mucosal mast cells: enumeration in urticaria pigmentosa and systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

A fatal case of portal hypertension complicating systemic mastocytosis in an adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Recurrent gastrointestinal bleeding associated with myelofibrosis and diffuse intestinal telangiectasias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Analysis of plasma histamine levels in patients with mast cell disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Urticaria pigmentosa: Treatment with cimetidine andchlorpheniramine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

1 reference

7 January 2021

MASTOCYTOSIS MANIFESTED BY HEPATOSPLENOMEGALY. REPORT OF A CASE

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Histamine metabolism in mastocytosis patients treated with interferon alpha-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Studies on histamine metabolism in mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Southwestern Internal Medicine Conference: mastocytosis: developments during the past decade.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis--central nervous system features and lymphographic demonstration of lymph node involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

[Shock and coagulation disorders in systemic mastocytosis]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis--a case treated with interferon alpha and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Effect of Cimetidine on Gastric Hypersecretion and Diarrhea in Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Cromolyn sodium in the management of systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Liver findings in generalized mastocytosis. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Spleen findings in generalized mastocytosis. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Radiological features of systemic mast-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Clinical stable systemic mastocytosis with interferon alpha-2b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Thyrotropin-releasing hormone suppressed gastric acid output in patients with Zollinger-Ellison syndrome and systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Malignant systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Mastocytosis of the gastrointestinal tract. Report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Mastocytosis (urticaria pigmentosa) of skin, stomach, and gut with malabsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis and mastocytosis-like syndrome: radiologic features of gastrointestinal manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Pentagastrin-induced stimulation of protein synthesis in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Radiotherapy of refractory bone pain due to systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Effect of large doses of histamine on gastric secretion of HCI; an augmented histamine test

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Hyperchlorhydria and Hyperhistaminemia in a Patient with Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Response to interferon alfa-2b in a patient with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Long-term follow-up of indolent mastocytosis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

[Hepatomegaly with portal hypertension indicative of systemic mastocytosis]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Bone Lesions of Urticaria Pigmentosa in Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Mast cells and mast cell neoplasia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Anaesthetic management of systemic mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Evaluation of anorectal physiology in patients with increased mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Aspirin and systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Hypercalcitoninaemia in a patient with urticaria pigmentosa. A possible cause of diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

The effect of prolonged histamine stimulation on the parietal cell population and the secretory function of the guineapig stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Achalasia due to diffuse esophageal leiomyomatosis and inherited as an autosomal dominant disorder. Report of a family study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mast cell disease with splenic infarction: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Cimetidine pharmacokinetics in patients with Zollinger-Ellison syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Classification and diagnosis of mastocytosis: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

The liver, spleen, and lymph nodes in mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

The treatment of mastocytosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Case report of bone mastocytosis: total hip arthroplasty for osteoarthritis and open reduction for condylar fracture of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Bone changes in urticaria pigmentosa. A report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

SYSTEMIC MAST CELL DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Portal hypertension and ascites in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Plasma concentrations and urinary excretion of regulatory peptides in patients with urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Treatment of systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Tissue mast cells in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis associated with chronic myelomonocytic leukemia: clinical features and response to interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Long-term response to interferon-alpha in a patient with systemic mastocytosis and chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Bull's-eye lesions: a new gastrointestinal presentation of mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Experimental alterations in gastric mucosal cellular population in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Gastrointestinal mastocytosis: radiologic alterations after ethanol ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Biochemical diagnosis of systemic mast cell disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mast cell disease in a patient with unusual gastrointestinal and pulmonary abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Anesthetic considerations in mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mastocytosis, myelofibrosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Severe shock during upper GI endoscopy in a patient with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Endoscopic findings in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Involvement of the small intestine in systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Hazards in Operative Management of Patients with Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mast cell disease with marrow and splenic involvement associated with chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Oral disodium cromoglycate in the treatment of systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Variceal bleeding, hypersplenism, and systemic mastocytosis. Pathophysiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Cutaneous mastocytosis in adults. evaluation of 14 patients with respect to systemic disease manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Urticaria pigmentosa: a clinical, hematopathologic, and serologic study of 30 adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Mast cell leukemia: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Significance of systemic mast cell disease with associated hematologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Intervention with epinephrine in hypotension associated with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Mast Cells and Myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Systemic mast cell disease: a clinical and hematopathologic study of 26 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Zollinger-Ellison syndrome. Current concepts in diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Treatment of three patients with systemic mastocytosis with interferon alpha-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Hepatic involvement in systemic mast cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Increased plasma calcitonin levels in systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

Osseous lesions in urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970298-7

7 January 2021

10.1016/S0889-8588(05)70298-7

Identifiers

DOI

1 reference

30 July 2017

1 reference